As Ireland’s Second One Health Nation Action Plan (iNAP2) on AMR concludes, the Microbiology Society urges a stronger role for researchers in shaping the next phase of national policy. These recommendations are based on views gathered from its community of Irish microbiologists through a series of workshops and surveys held in November and December 2024. The aim was to assess the current AMR research and development (R&D) landscape in Ireland and guide the formation of the upcoming iNAP3.
In January 2024, the Microbiology Society hosted a series of solution-oriented, invite-only workshops dedicated to our priority solution areas: diagnostics, surveillance, therapeutics and vaccines. Read the full workshop reports here.
Last week, the UK Government published the latest five-year AMR National Action Plan (NAP) “Confronting Antimicrobial Resistance”, which aims to take the UK closer to reaching its vision of containing and controlling AMR by 2040.
Antimicrobial resistance (AMR) is a real and current threat to healthcare systems and economies across the world. Today, AMR is a leading cause of death worldwide, killing more people than HIV and malaria combined.
